Hi Jase
Gene editing is certainly not my field.
I was wondering what the FDA's response would be to a 'crafted' trial that only accepted patients showing a higher level of T cell diversity.
The response rate could be phenomenal ... and lead to a very fast approval. Of course, I could be dreaming too.
Just my musings.
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-49
-
- There are more pages in this discussion • 256 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $401.6M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $1.182M | 21.47M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 3441484 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 574188 | 6 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |